MEK Resistance via Amphiregulin Mediated EGFR-STAT3 Activation in Pancreatic Cancer
Publication
, Conference
Lamichhane, P; Nagathihalli, NS; Castellanos, J; Shi, C; Roberts, C; Vansaun, M; Merchant, N
Published in: PANCREAS
November 1, 2016
Duke Scholars
Published In
PANCREAS
EISSN
1536-4828
ISSN
0885-3177
Publication Date
November 1, 2016
Volume
45
Issue
10
Start / End Page
1518 / 1518
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Gastroenterology & Hepatology
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Lamichhane, P., Nagathihalli, N. S., Castellanos, J., Shi, C., Roberts, C., Vansaun, M., & Merchant, N. (2016). MEK Resistance via Amphiregulin Mediated EGFR-STAT3 Activation in Pancreatic Cancer. In PANCREAS (Vol. 45, pp. 1518–1518). LIPPINCOTT WILLIAMS & WILKINS.
Lamichhane, P., N. S. Nagathihalli, J. Castellanos, C. Shi, C. Roberts, M. Vansaun, and N. Merchant. “MEK Resistance via Amphiregulin Mediated EGFR-STAT3 Activation in Pancreatic Cancer.” In PANCREAS, 45:1518–1518. LIPPINCOTT WILLIAMS & WILKINS, 2016.
Lamichhane P, Nagathihalli NS, Castellanos J, Shi C, Roberts C, Vansaun M, et al. MEK Resistance via Amphiregulin Mediated EGFR-STAT3 Activation in Pancreatic Cancer. In: PANCREAS. LIPPINCOTT WILLIAMS & WILKINS; 2016. p. 1518–1518.
Lamichhane, P., et al. “MEK Resistance via Amphiregulin Mediated EGFR-STAT3 Activation in Pancreatic Cancer.” PANCREAS, vol. 45, no. 10, LIPPINCOTT WILLIAMS & WILKINS, 2016, pp. 1518–1518.
Lamichhane P, Nagathihalli NS, Castellanos J, Shi C, Roberts C, Vansaun M, Merchant N. MEK Resistance via Amphiregulin Mediated EGFR-STAT3 Activation in Pancreatic Cancer. PANCREAS. LIPPINCOTT WILLIAMS & WILKINS; 2016. p. 1518–1518.
Published In
PANCREAS
EISSN
1536-4828
ISSN
0885-3177
Publication Date
November 1, 2016
Volume
45
Issue
10
Start / End Page
1518 / 1518
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Gastroenterology & Hepatology
- 3202 Clinical sciences
- 1103 Clinical Sciences